Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Russia will have its first quadrivalent influenza vaccine
According to the experts, this vaccine has not only the most effective and safe profile possible today, but also provides undeniable pharmacoeconomic advantages.
A memorandum signed to promote Russian products onto the Chilean market
The representatives of the Public Health Institute of Chile visited a vaccine production facility of St. Petersburg Institute of Vaccines and Serums in order to continue and expand cooperation between Russia and Chile.
St. Petersburg Institute of Vaccines and Serums joins DCVMN
In November 2017, St. Petersburg Institute of Vaccines and Serums joined the Developing Countries Vaccine Manufacturers Network
Chile interested in expanding cooperation with St. Petersburg Research Institute
A meeting between the representatives of Instituto de Salud Pública, Chile, and St. Petersburg Research Institute of Vaccines and Serums was held in St. Petersburg.
Russia enters the market of TB diagnosis services in Latin America
In early August, the first lot of Russian-made diagnostic drug for detecting TB at early stages was delivered to Cuba.
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
V.P. Filatov Pharmaceutical Plant
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
Conference GEP-Russia 2017: Sterile Forms and Biotechnology
MIPT delivers world’s first biosensor chips of unprecedented...
German CDMO HERMES PHARMA receives Russian GMP certification...
Amgen will transfer technology for manufacturing of blinatum...
Subscribe to Newsletter!
© GMP news